This inventor holds 1 USPTO granted patent. Top assignee: Targacept, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Joesph Pike Mitchener, Jr. - Innovator in Pharmaceutical Compounds
Introduction
Joesph Pike Mitchener, Jr. is a notable inventor based in Winston-Salem, North Carolina, recognized for his innovative contributions to the pharmaceutical field. With a background in chemistry and a focus on synthesis, he has developed significant methods and compounds that hold promise for medical applications.
Latest Patents
Mitchener holds a patent for the invention titled "Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine." This invention pertains to (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine and its salt forms. The patent outlines the processes for the commercial-scale production of these compounds, ensuring they meet the necessary purity and quality standards for use in pharmaceutical formulations.
Career Highlights
Mitchener is affiliated with Targacept, Inc., a company dedicated to developing innovative pharmaceutical candidates. His work at Targacept involves leveraging his chemistry expertise to create novel compounds that could potentially transform treatments for various diseases.
Collaborations
Throughout his career, Mitchener has collaborated with talented colleagues, including Srinivasa Rao Akireddy and Scott R. Breining. These collaborations illustrate the importance of teamwork in advancing research and bringing innovative solutions to the pharmaceutical industry.
Conclusion
Joesph Pike Mitchener, Jr. exemplifies the spirit of innovation within the pharmaceutical sector. His contributions, encapsulated in his patent and collaborative efforts, reflect a commitment to creating effective therapeutic solutions that can benefit patients worldwide. His ongoing work at Targacept continues to inspire advancements in drug development and synthesis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile